Literature DB >> 24477886

First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical management.

E Lemmenmeier1, P Kohler, T Bruderer, D Goldenberger, G-R Kleger, M Schlegel.   

Abstract

We report the epidemiological and clinical features of the first outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) type 2 in Switzerland. The outbreak took place in the medical intensive care unit (MICU) of our tertiary care hospital and affected three severely ill patients. After the implementation of strict infection control measures, no further patients colonised with KPC-KP could be detected by the screening of exposed patients. Successful treatment of patients infected with KPC-KP consisted of a combination therapy of meropenem, colistin and tigecycline.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477886     DOI: 10.1007/s15010-013-0578-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

1.  Nosocomial outbreak of Klebsiella pneumoniae harbouring bla(KPC-3) in France subsequent to a patient transfer from Italy.

Authors:  Gaelle Cuzon; Thierry Naas; Marie-Claude Demachy; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2012-03-13       Impact factor: 5.283

2.  Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland.

Authors:  Laurent Poirel; Reto Lienhard; Anaïs Potron; Raffaele Malinverni; Hans H Siegrist; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2010-12-29       Impact factor: 5.790

3.  Comparison of the DiversiLab repetitive element PCR system with spa typing and pulsed-field gel electrophoresis for clonal characterization of methicillin-resistant Staphylococcus aureus.

Authors:  B Babouee; R Frei; E Schultheiss; A F Widmer; D Goldenberger
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

Review 4.  Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria.

Authors:  M Akova; G L Daikos; L Tzouvelekis; Y Carmeli
Journal:  Clin Microbiol Infect       Date:  2012-05       Impact factor: 8.067

5.  Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10.

Authors:  B Babouee; A F Widmer; O Dubuis; D Ciardo; S Droz; B Y Betsch; C Garzoni; U Führer; M Battegay; R Frei; D Goldenberger
Journal:  Euro Surveill       Date:  2011-03-17

6.  Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.

Authors:  Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

7.  Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome.

Authors:  Cecile Aubron; Allen C Cheng; David Pilcher; Tim Leong; Geoff Magrin; D Jamie Cooper; Carlos Scheinkestel; Vince Pellegrino
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-21       Impact factor: 3.254

Review 8.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

9.  Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011.

Authors:  T Giani; B Pini; F Arena; V Conte; S Bracco; R Migliavacca; A Pantosti; L Pagani; F Luzzaro; G M Rossolini
Journal:  Euro Surveill       Date:  2013-05-30

10.  In vitro activity of carbapenems alone and in combination with amikacin against KPC-producing Klebsiella pneumoniae.

Authors:  Jennifer Le; Barbara McKee; Warunee Srisupha-Olarn; David S Burgess
Journal:  J Clin Med Res       Date:  2011-05-19
View more
  5 in total

1.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  An optimized work-flow to reduce time-to-detection of carbapenemase-producing Enterobacteriaceae (CPE) using direct testing from rectal swabs.

Authors:  C O'Connor; M G Kiernan; C Finnegan; M O'Hara; L Power; N H O'Connell; C P Dunne
Journal:  Bioengineered       Date:  2016-08-17       Impact factor: 3.269

3.  Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018.

Authors:  Alban Ramette; Michael Gasser; Patrice Nordmann; Reinhard Zbinden; Jacques Schrenzel; Damir Perisa; Andreas Kronenberg
Journal:  Euro Surveill       Date:  2021-04

Review 4.  Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.

Authors:  David M Jacobs; M Courtney Safir; Dennis Huang; Faisal Minhaj; Adam Parker; Gauri G Rao
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-11-25       Impact factor: 3.944

5.  Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018.

Authors:  Stefanie Barnsteiner; Florent Baty; Werner C Albrich; Baharak Babouee Flury; Michael Gasser; Catherine Plüss-Suard; Matthias Schlegel; Andreas Kronenberg; Philipp Kohler
Journal:  Euro Surveill       Date:  2021-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.